We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0K3C market cap is 270.78M. The company's latest EPS is BGN 0.8761 and P/E is 9.02.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Revenue | 958.58M | 1.17B | 1.34B | 1.49B | 1.68B |
| Operating Income | 11.94M | 21.37M | 18.03M | 43.75M | 48.72M |
| Net Income | 8.92M | 11.48M | 8.05M | 9.08M | 30.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Assets | 483.31M | 616.53M | 582.86M | 572.55M | 640.35M |
| Total Liabilities | 407.51M | 539.59M | 497.96M | 478.01M | 516.32M |
| Total Equity | 75.8M | 76.94M | 84.9M | 94.55M | 124.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Operating | -181.95M | -217.09M | -172.86M | 18.58M | 47.96M |
| Investing | -22.55M | -9.99M | -14.33M | -12.15M | -25.8M |
| Financing | 207.86M | 226.83M | 191.75M | -11.29M | -15.88M |
| Market Cap | 270.78M |
| Price to Earnings Ratio | 9.02 |
| Price to Sales Ratio | 0.16 |
| Price to Cash Ratio | 20.64 |
| Price to Book Ratio | 2.18 |
| Dividend Yield | - |
| Shares Outstanding | 34.28M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Sopharma Trading Ad |
| Address |
ul. lachezar stanchev 5 sofia 1756 |
| Website | https://www.sopharmatrading.bg |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
